Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts.

During the past decade, Dana Farber Cancer Institute conducted 1628 clinical trials. In the 10-year time frame, 1628 clinical trials started and 921 clinical trials were completed, i.e. on average, 56.6% percent of trials that started reached the finish line to date. In the past 5 years, 675 clinical trials started and 477 clinical trials were completed. i.e. 70.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dana Farber Cancer Institute" #1 sponsor was "Dana-Farber Cancer Institute" with 697 trials, followed by "National Cancer Institute (NCI)" with 319 trials sponsored, "Massachusetts General Hospital" with 161 trials sponsored, "Children's Oncology Group" with 156 trials sponsored and "Alliance for Clinical Trials in Oncology" with 156 trials sponsored. Other sponsors include 1749 different institutions and companies that sponsored additional 564 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dana Farber Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 582 trials as a collaborator, "Brigham and Women's Hospital" with 229 trials as a collaborator, "Dana-Farber Cancer Institute" with 159 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 141 trials as a collaborator and "Massachusetts General Hospital" with 138 trials as a collaborator. Other collaborators include 2016 different institutions and companies that were collaborators in the rest 586 trials.

According to Clinical.Site data, the most researched conditions in "Dana Farber Cancer Institute" are "Breast Cancer" (240 trials), "Multiple Myeloma" (139 trials), "Prostate Cancer" (115 trials), "Leukemia" (91 trials) and "Ovarian Cancer" (85 trials). Many other conditions were trialed in "Dana Farber Cancer Institute" in a lesser frequency.

Most popular intervention types in "Dana Farber Cancer Institute" are "Drug" (2585 trials), "Biological" (523 trials), "Other" (499 trials), "Procedure" (325 trials) and "Radiation" (267 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (177 trials), "Nivolumab" (132 trials), "Placebo" (121 trials), "Cyclophosphamide" (115 trials) and "Pembrolizumab" (100 trials). Other intervention names were less common.

The vast majority of trials in "Dana Farber Cancer Institute" are 2790 trials for "All" genders, 278 trials for "Female" genders and 139 trials for "Male" genders.

Currently, there are 1229 active trials in "Dana Farber Cancer Institute". 18 are not yet recruiting, 569 are recruiting, 633 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 1514 completed trials in Dana Farber Cancer Institute, 25 suspended trials, and 336 terminated clinical trials to date.

Out of the total trials that were conducted in Dana Farber Cancer Institute, 1136 "Phase 1" clinical trials were conducted, 1613 "Phase 2" clinical trials and 458 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 226 trials that are defined as “Not Applicable".

Dana Farber Cancer Institute has several departments that took part in Clinical trials: "Dana-Farber/Brigham and Women's Cancer Center at Milford Regional" - 56 trials, "Dana Farber Community Cancer Care-Quincy" - 39 trials, "The Dana-Farber Cancer Institute at Londonderry" - 38 trials, "Massachusetts General Hospital, Dana-Farber Cancer Institute" - 25 trials, "Dana Farber-Merrimack Valley" - 11 trials, "Dana-Farber Cancer Institute - Chestnut Hill" - 8 trials, "Dana-Farber/ Partners Cancer Care, Inc." - 7 trials, "Dana Farber Cancer Inst. ; Dept. of Medical Oncology" - 7 trials, "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center" - 5 trials, "Dana-Farber Brigham Cancer Center - Foxborough" - 5 trials, "Dana Farber Cancer Institute Centerfor Sarcoma&BoneOncology" - 4 trials, "Dana Farber Community Cancer Care-Stoneham" - 4 trials, "Dana Farber Cancer Institute/Pharmacy" - 2 trials, "Dana Farber Cancer Institute Clinical Research Coordinator" - 2 trials, "Dana-Farber Cancer Institute Breast Oncology" - 2 trials, "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program" - 2 trials